Birth control pills reduce risks for certain cancers

A study spanning generations found that birth control pills may protect women against more than just unplanned pregnancies. They may decrease cancer rates as well.

Researchers from Sctoland's University of Aberdeen, after four decades of data collection, have found women who used birth control pills are more protected from cancers for 30 years or more. Data from 46,000 women collected over 44 years suggest rates of colorectal, endometrial and ovarian cancer rates were significantly lowered by those who also took birth control.

“Because the study has been going for such a long time we are able to look at the very long term effects, if there are any, associated with the pill," said Lisa Iversen, PhD, MSc, Research Fellow at the University of Aberdeen's Institute of Applied Health Sciences, in a release. “What we found from looking at up to 44 years of data was that having ever used the pill women are less likely to get colorectal, endometrial and ovarian cancer.”

Read the full story by clicking below:

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.